- Home
- CHCT vs IMNM Comparison
CHCT vs IMNM Comparison
Compare CHCT & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHCT
- IMNM
- Stock Information
- Founded
- CHCT 2014
- IMNM 2006
- Country
- CHCT United States
- IMNM United States
- Employees
- CHCT N/A
- IMNM N/A
- Industry
- CHCT Real Estate Investment Trusts
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- CHCT Real Estate
- IMNM Health Care
- Exchange
- CHCT Nasdaq
- IMNM Nasdaq
- Market Cap
- CHCT 559.3M
- IMNM 585.5M
- IPO Year
- CHCT 2015
- IMNM 2020
- Fundamental
- Price
- CHCT $20.00
- IMNM $11.08
- Analyst Decision
- CHCT Buy
- IMNM Strong Buy
- Analyst Count
- CHCT 4
- IMNM 5
- Target Price
- CHCT $21.25
- IMNM $28.60
- AVG Volume (30 Days)
- CHCT 186.8K
- IMNM 1.0M
- Earning Date
- CHCT 02-18-2025
- IMNM 03-27-2025
- Dividend Yield
- CHCT 9.19%
- IMNM N/A
- EPS Growth
- CHCT N/A
- IMNM N/A
- EPS
- CHCT N/A
- IMNM N/A
- Revenue
- CHCT $115,612,000.00
- IMNM $10,129,000.00
- Revenue This Year
- CHCT N/A
- IMNM N/A
- Revenue Next Year
- CHCT $7.55
- IMNM N/A
- P/E Ratio
- CHCT N/A
- IMNM N/A
- Revenue Growth
- CHCT 6.00
- IMNM N/A
- 52 Week Low
- CHCT $15.06
- IMNM $8.97
- 52 Week High
- CHCT $28.10
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- CHCT 49.80
- IMNM 54.91
- Support Level
- CHCT $19.39
- IMNM $10.29
- Resistance Level
- CHCT $20.87
- IMNM $11.43
- Average True Range (ATR)
- CHCT 0.52
- IMNM 0.77
- MACD
- CHCT -0.06
- IMNM 0.18
- Stochastic Oscillator
- CHCT 20.56
- IMNM 85.23
About CHCT Community Healthcare Trust Incorporated
Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.